AAAAAA
Results:
1-12
|
Results: 12
Authors:
SEGALL M
NOREEN H
EDWINS L
HAAKE R
SHU XO
KERSEY J
Citation: M. Segall et al., LACK OF CORRELATION OF MLC REACTIVITY WITH ACUTE GRAFT-VERSUS-HOST DISEASE AND MORTALITY IN UNRELATED DONOR BONE-MARROW TRANSPLANTATION, Human immunology, 49(1), 1996, pp. 49-55
Authors:
ENRIGHT H
DAVIES SM
DEFOR T
SHU X
WEISDORF D
MILLER W
RAMSAY NKC
ARTHUR D
VERFAILLIE C
MILLER J
KERSEY J
MCGLAVE P
Citation: H. Enright et al., RELAPSE AFTER NON-T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA - EARLY TRANSPLANTATION USE OF ANUNRELATED DONOR, AND CHRONIC GRAFT-VERSUS-HOST DISEASE ARE PROTECTIVE, Blood, 88(2), 1996, pp. 714-720
Authors:
SMITH FO
RAUCH C
WILLIAMS DE
MARCH CJ
ARTHUR D
HILDEN J
LAMPKIN BC
BUCKLEY JD
BUCKLEY CV
WOODS WG
DINNDORF PA
SORENSEN P
KERSEY J
HAMMOND D
BERNSTEIN ID
Citation: Fo. Smith et al., THE HUMAN HOMOLOG OF RAT NG2, A CHONDROITIN SULFATE PROTEOGLYCAN, IS NOT EXPRESSED ON THE CELL-SURFACE OF NORMAL HEMATOPOIETIC-CELLS BUT ISEXPRESSED BY ACUTE MYELOID-LEUKEMIA BLASTS FROM POOR-PROGNOSIS PATIENTS WITH ABNORMALITIES OF CHROMOSOME BAND 11Q23, Blood, 87(3), 1996, pp. 1123-1133
GENETIC SERVICES FOR FAMILIAL CANCER-PATIENTS - A SURVEY OF NATIONAL-CANCER-INSTITUTE CANCER CENTERS
Authors:
THOMPSON JA
WIESNER GL
SELLERS TA
VACHON C
AHRENS M
POTTER JD
SUMPMANN M
KERSEY J
Citation: Ja. Thompson et al., GENETIC SERVICES FOR FAMILIAL CANCER-PATIENTS - A SURVEY OF NATIONAL-CANCER-INSTITUTE CANCER CENTERS, Journal of the National Cancer Institute, 87(19), 1995, pp. 1446-1455
Authors:
FRESTEDT J
HILDEN J
MOORE R
KERSEY J
Citation: J. Frestedt et al., A NOVEL PRC-BASED TECHNIQUE FOR IDENTIFYING INTRON-EXON BOUNDARIES, The FASEB journal, 9(3), 1995, pp. 504-504
Authors:
ENRIGHT H
DAVIES S
SHU X
MILLER W
WEISDORF D
VERFAILLIE C
MILLER J
ARTHUR D
DUSENBURY K
RAMSAY N
KERSEY J
VERCELLOTTI G
MCGLAVE P
Citation: H. Enright et al., HIGHER INCIDENCE OF RELAPSE IN RELATED COMPARED WITH UNRELATED DONOR RECIPIENTS FOLLOWING ALLOGENEIC MARROW TRANSPLANT FOR CML - ANALYSIS IN 290 PATIENTS, Blood, 84(10), 1994, pp. 10000336-10000336
Authors:
WEISDORF D
FILIPOVICH A
MCGLAVE P
RAMSAY N
KERSEY J
MILLER W
BLAZAR B
Citation: D. Weisdorf et al., COMBINATION GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS USING IMMUNOTOXIN (ANTI-CD5-RTA [XOMAZYME-CD5]) PLUS METHOTREXATE AND CYCLOSPORINE OR PREDNISONE AFTER UNRELATED DONOR MARROW TRANSPLANTATION, Bone marrow transplantation, 12(5), 1993, pp. 531-536
Authors:
NOREEN H
EDWINS L
HAAKE R
KERSEY J
SEGALL M
Citation: H. Noreen et al., LACK OF CORRELATION OF MLC REACTIVITY WITH ACUTE GRAFT-VS-HOST DISEASE IN UNRELATED BONE-MARROW TRANSPLANTATION, Human immunology, 37, 1993, pp. 83-83
Authors:
ENRIGHT H
HAAKE R
WEISDORF D
RAMSAY N
MCGLAVE P
KERSEY J
THOMAS W
MCKENZIE D
MILLER W
Citation: H. Enright et al., CYTOMEGALOVIRUS PNEUMONIA AFTER BONE-MARROW TRANSPLANTATION - RISK-FACTORS AND RESPONSE TO THERAPY, Transplantation, 55(6), 1993, pp. 1339-1346
Authors:
KERSEY J
FILIPOVICH A
MCGLAVE P
WOODS W
WEISDORF D
NEGLIA J
DUSENBERY K
BLAZAR B
NESBIT M
RAMSAY N
Citation: J. Kersey et al., DONOR AND HOST INFLUENCES IN BONE-MARROW TRANSPLANTATION FOR IMMUNODEFICIENCY DISEASE AND LEUKEMIA, Seminars in hematology, 30(4), 1993, pp. 105-109
Authors:
ENRIGHT H
DANIELS K
WEISDORF D
MILLER W
KERSEY J
RAMSAY N
VERCELLOTTI G
DUSENBERY K
MCGLAVE P
Citation: H. Enright et al., RISK-FACTORS IN MARROW TRANSPLANT FOR CML - OVERWHELMING INFLUENCE OFEARLY TRANSPLANT, Blood, 82(10), 1993, pp. 10000165-10000165
Authors:
WEISDORF D
DANIELS K
MILLER W
BLAZAR B
PERRY E
RAMSAY N
MCGLAVE P
KERSEY J
Citation: D. Weisdorf et al., BONE-MARROW VS PERIPHERAL-BLOOD STEM-CELLS FOR AUTOLOGOUS LYMPHOMA TRANSPLANTATION - A PROSPECTIVE RANDOMIZED TRIAL, Blood, 82(10), 1993, pp. 10000444-10000444
Risultati:
1-12
|